{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T10:11:44Z","timestamp":1766139104647,"version":"3.38.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-025-03863-2","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T12:36:43Z","timestamp":1741696603000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Integrative analysis of DNA methylation and gene expression in skin cutaneous melanoma by bioinformatic approaches"],"prefix":"10.1007","volume":"317","author":[{"given":"Liming","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuchuan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,11]]},"reference":[{"key":"3863_CR1","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.3390\/ijms19102889","volume":"19","author":"H Tanaka","year":"2018","unstructured":"Tanaka H, Yamashita Y, Umezawa K, Hirobe T, Ito S, Wakamatsu K (2018) The pro-oxidant activity of pheomelanin is significantly enhanced by UVA irradiation: benzothiazole moieties are more reactive than benzothiazine moieties. Int J Mol Sci 19:2889","journal-title":"Int J Mol Sci"},{"key":"3863_CR2","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.jaad.2018.08.055","volume":"80","author":"SM Swetter","year":"2019","unstructured":"Swetter SM, Tsao H, Bichakjian CK, Curiel-Lewandrowski C, Elder DE, Gershenwald JE, Guild V, Grant-Kels JM, Halpern AC, Johnson TM, Sober AJ, Thompson JA, Wisco OJ, Wyatt S, Hu S, Lamina T, Work G (2019) Guidelines of care for the management of primary cutaneous melanoma. J Am Acad Dermatol 80:208\u2013250","journal-title":"J Am Acad Dermatol"},{"key":"3863_CR3","doi-asserted-by":"publisher","first-page":"4108","DOI":"10.1002\/cncr.29634","volume":"121","author":"SA Weiss","year":"2015","unstructured":"Weiss SA, Hanniford D, Hernando E, Osman I (2015) Revisiting determinants of prognosis in cutaneous melanoma. Cancer 121:4108\u20134123","journal-title":"Cancer"},{"key":"3863_CR4","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s40291-018-0318-z","volume":"22","author":"A Eisenstein","year":"2018","unstructured":"Eisenstein A, Gonzalez EC, Raghunathan R, Xu X, Wu M, McLean EO, McGee J, Ryu B, Alani RM (2018) Emerging biomarkers in cutaneous melanoma. Mol Diagn Ther 22:203\u2013218","journal-title":"Mol Diagn Ther"},{"key":"3863_CR5","first-page":"404","volume":"43","author":"C Ci","year":"2019","unstructured":"Ci C, Tang B, Lyu D, Liu W, Qiang D, Ji X, Qiu X, Chen L, Ding W (2019) Overexpression of CDCA8 promotes the malignant progression of cutaneous melanoma and leads to poor prognosis. Int J Mol Med 43:404\u2013412","journal-title":"Int J Mol Med"},{"key":"3863_CR6","doi-asserted-by":"publisher","first-page":"5133","DOI":"10.1002\/jcp.26395","volume":"233","author":"CL Ross","year":"2018","unstructured":"Ross CL, Kaushik S, Valdes Rodriguez R, Anvekar R (2018) MicroRNAs in cutaneous melanoma: role as diagnostic and prognostic biomarkers. J Cell Physiol 233:5133\u20135141","journal-title":"J Cell Physiol"},{"key":"3863_CR7","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1097\/CMR.0000000000000631","volume":"29","author":"H Hu","year":"2019","unstructured":"Hu H, Li Z, Zhou Y, Zhang Y, Zhao L, Zhao W, Huang Y, Song X (2019) GLT8D1 overexpression as a novel prognostic biomarker in human cutaneous melanoma. Melanoma Res 29:612\u2013620","journal-title":"Melanoma Res"},{"key":"3863_CR8","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.it.2019.02.004","volume":"40","author":"AA Emran","year":"2019","unstructured":"Emran AA, Chatterjee A, Rodger EJ, Tiffen JC, Gallagher SJ, Eccles MR, Hersey P (2019) Targeting DNA methylation and EZH2 activity to overcome melanoma resistance to immunotherapy. Trends Immunol 40:328\u2013344","journal-title":"Trends Immunol"},{"key":"3863_CR9","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1080\/15592294.2014.1003746","volume":"10","author":"D Sarkar","year":"2015","unstructured":"Sarkar D, Leung EY, Baguley BC, Finlay GJ, Askarian-Amiri ME (2015) Epigenetic regulation in human melanoma: past and future. Epigenetics 10:103\u2013121","journal-title":"Epigenetics"},{"key":"3863_CR10","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/ng1834","volume":"38","author":"DJ Weisenberger","year":"2006","unstructured":"Weisenberger DJ, Siegmund KD, Campan M, Young J, Long TI, Faasse MA, Kang GH, Widschwendter M, Weener D, Buchanan D, Koh H, Simms L, Barker M, Leggett B, Levine J, Kim M, French AJ, Thibodeau SN, Jass J, Haile R, Laird PW (2006) CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 38:787\u2013793","journal-title":"Nat Genet"},{"key":"3863_CR11","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1167\/iovs.06-0781","volume":"48","author":"W Maat","year":"2007","unstructured":"Maat W, van der Velden PA, Out-Luiting C, Plug M, Dirks-Mulder A, Jager MJ, Gruis NA (2007) Epigenetic inactivation of RASSF1a in uveal melanoma. Invest Ophth Vis Sci 48:486\u2013490","journal-title":"Invest Ophth Vis Sci"},{"key":"3863_CR12","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1158\/1541-7786.MCR-10-0437","volume":"9","author":"A Calipel","year":"2011","unstructured":"Calipel A, Abonnet V, Nicole O, Mascarelli F, Coupland SE, Damato B, Mouriaux F (2011) Status of RASSF1A in uveal melanocytes and melanoma cells. Mol Cancer Res 9:1187\u20131198","journal-title":"Mol Cancer Res"},{"key":"3863_CR13","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.det.2019.06.001","volume":"37","author":"JB Dowling","year":"2019","unstructured":"Dowling JB, McGregor SPDP, Williford PM (2019) Update on current treatment recommendations for primary cutaneous melanoma. Dermatol Clin 37:397\u2013407","journal-title":"Dermatol Clin"},{"key":"3863_CR14","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1097\/DAD.0b013e31828a2ec5","volume":"36","author":"O Abbas","year":"2014","unstructured":"Abbas O, Miller DD, Bhawan J (2014) Cutaneous malignant melanoma: update on diagnostic and prognostic biomarkers. Am J Dermatopathol 36:363\u2013379","journal-title":"Am J Dermatopathol"},{"key":"3863_CR15","doi-asserted-by":"publisher","first-page":"6692","DOI":"10.1158\/0008-5472.CAN-06-0801","volume":"66","author":"T Mori","year":"2006","unstructured":"Mori T, Martinez SR, O\u2019Day SJ, Morton DL, Umetani N, Kitago M, Tanemura A, Nguyen SL, Tran AN, Wang H, Hoon DSB (2006) Estrogen receptor-alpha methylation predicts melanoma progression. Cancer Res 66:6692\u20136698","journal-title":"Cancer Res"},{"key":"3863_CR16","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1158\/1078-0432.CCR-08-1361","volume":"15","author":"A Tanemura","year":"2009","unstructured":"Tanemura A, Terando AM, Sim M-S, van Hoesel AQ, de Maat MFG, Morton DL, Hoon DSB (2009) CpG island methylator phenotype predicts progression of malignant melanoma. Clin Cancer Res 15:1801\u20131807","journal-title":"Clin Cancer Res"},{"key":"3863_CR17","doi-asserted-by":"publisher","first-page":"6111","DOI":"10.1158\/0008-5472.CAN-05-4198","volume":"66","author":"K Koyanagi","year":"2006","unstructured":"Koyanagi K, Mori T, O\u2019Day SJ, Martinez SR, Wang H, Hoon DSB (2006) Association of circulating tumor cells with serum tumor-related methylated DNA in peripheral blood of melanoma patients. Cancer Res 66:6111\u20136117","journal-title":"Cancer Res"},{"key":"3863_CR18","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1038\/jid.2012.36","volume":"132","author":"S Hoshimoto","year":"2012","unstructured":"Hoshimoto S, Kuo CT, Chong KK, Takeshima T, Takei Y, Li MW, Huang SK, Sim M, Morton DL, Hoon DSB (2012) AIM1 and LINE-1 epigenetic aberrations in tumor and serum relate to melanoma progression and disease outcome. J Invest Dermatol 132:1689\u20131697","journal-title":"J Invest Dermatol"},{"key":"3863_CR19","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1093\/hmg\/ddt420","volume":"23","author":"DM Marzese","year":"2014","unstructured":"Marzese DM, Scolyer RA, Huynh JL, Huang SK, Hirose H, Chong KK, Kiyohara E, Wang J, Kawas NP, Donovan NC, Hata K, Wilmott JS, Murali R, Buckland ME, Shivalingam B, Thompson JF, Morton DL, Kelly DF, Hoon DSB (2014) Epigenome-wide DNA methylation landscape of melanoma progression to brain metastasis reveals aberrations on homeobox D cluster associated with prognosis. Hum Mol Genet 23:226\u2013238","journal-title":"Hum Mol Genet"},{"key":"3863_CR20","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13578-016-0077-7","volume":"6","author":"K Gaston","year":"2016","unstructured":"Gaston K, Tsitsilianos M, Wadey K, Jayaraman P (2016) Misregulation of the proline rich homeodomain (PRH\/HHEX) protein in cancer cells and its consequences for tumour growth and invasion. Cell Biosci 6:12","journal-title":"Cell Biosci"},{"key":"3863_CR21","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1128\/MCB.01511-09","volume":"30","author":"P Noy","year":"2010","unstructured":"Noy P, Williams H, Sawasdichai A, Gaston K, Jayaraman P (2010) PRH\/Hhex controls cell survival through coordinate transcriptional regulation of vascular endothelial growth factor signaling. Mol Cell Biol 30:2120\u20132134","journal-title":"Mol Cell Biol"},{"key":"3863_CR22","doi-asserted-by":"publisher","first-page":"605744","DOI":"10.3389\/fcell.2020.605744","volume":"8","author":"K Zhang","year":"2020","unstructured":"Zhang K, Zhao Q, Li Z, Fu F, Zhang H, Fu J, Zheng M, Zhang S (2020) Clinicopathological significances of cancer stem cell-associated HHEX expression in breast cancer. Front Cell Dev Biol 8:605744","journal-title":"Front Cell Dev Biol"},{"key":"3863_CR23","doi-asserted-by":"publisher","first-page":"5592","DOI":"10.1038\/onc.2013.496","volume":"33","author":"RM Kershaw","year":"2014","unstructured":"Kershaw RM, Siddiqui YH, Roberts D, Jayaraman P, Gaston K (2014) PRH\/HHex inhibits the migration of breast and prostate epithelial cells through direct transcriptional regulation of Endoglin. Oncogene 33:5592\u20135600","journal-title":"Oncogene"},{"key":"3863_CR24","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/CMR.0b013e328338a35a","volume":"20","author":"C Schinke","year":"2010","unstructured":"Schinke C, Mo Y, Yu Y, Amiri K, Sosman J, Greally J, Verma A (2010) Aberrant DNA methylation in malignant melanoma. Melanoma Res 20:253\u2013265","journal-title":"Melanoma Res\u00a0"},{"key":"3863_CR25","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/ng.2764","volume":"45","author":"JN Weinstein","year":"2013","unstructured":"Weinstein JN, Collisson EA, Mills GB, Shaw KRM, Ozenberger BA, Ellrott K, Shmulevich I, Sander C, Stuart JM (2013) The cancer genome atlas pan-cancer analysis project. Nat Genet 45:1113\u20131120","journal-title":"Nat Genet"},{"key":"3863_CR26","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z (2017) GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res 45:W98\u2013W102","journal-title":"Nucleic Acids Res"},{"key":"3863_CR27","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","volume":"77","author":"T Li","year":"2017","unstructured":"Li T, Fan J, Wang B, Traugh N, Chen Q, Liu JS, Li B, Liu XS (2017) TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res 77:e108\u2013e110","journal-title":"Cancer Res"},{"key":"3863_CR28","doi-asserted-by":"publisher","first-page":"608","DOI":"10.3390\/nu11030608","volume":"11","author":"AM Mahmoud","year":"2019","unstructured":"Mahmoud AM, Ali MM (2019) Methyl donor micronutrients that modify DNA methylation and cancer outcome. Nutrients 11:608","journal-title":"Nutrients"},{"key":"3863_CR29","doi-asserted-by":"publisher","first-page":"5579","DOI":"10.18632\/aging.102139","volume":"11","author":"D Jia","year":"2019","unstructured":"Jia D, Lin W, Tang H, Cheng Y, Xu K, He Y, Geng W, Dai Q (2019) Integrative analysis of DNA methylation and gene expression to identify key epigenetic genes in glioblastoma. Aging (Albany NY) 11:5579\u20135592","journal-title":"Aging (Albany NY)"},{"key":"3863_CR30","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.4049\/jimmunol.1403134","volume":"194","author":"JM Tran Janco","year":"1950","unstructured":"Tran Janco JM, Lamichhane P, Karyampudi L, Knutson KL (1950) Tumor-infiltrating dendritic cells in cancer pathogenesis. J Immunol 194:2985\u20132991","journal-title":"J Immunol"},{"key":"3863_CR31","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.biopha.2017.08.003","volume":"95","author":"X Liu","year":"2017","unstructured":"Liu X, Wu S, Yang Y, Zhao M, Zhu G, Hou Z (2017) The prognostic landscape of tumor-infiltrating immune cell and immunomodulators in lung cancer. Biomed Pharmacother 95:55\u201361","journal-title":"Biomed Pharmacother"},{"key":"3863_CR32","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s40425-018-0391-1","volume":"6","author":"MW Rohaan","year":"2018","unstructured":"Rohaan MW, van den Berg JH, Kvistborg P, Haanen JBAG (2018) Adoptive transfer of tumor-infiltrating lymphocytes in melanoma: a viable treatment option. J\u00a0Immunother Cancer 6:102","journal-title":"J\u00a0Immunother Cancer"},{"key":"3863_CR33","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.jid.2016.01.024","volume":"136","author":"MR Roh","year":"2016","unstructured":"Roh MR, Gupta S, Park K, Chung KY, Lauss M, Flaherty KT, Jonsson G, Rha SY, Tsao H (2016) Promoter methylation of PTEN is a significant prognostic factor in Melanoma Survival. J Invest Dermatol 136:1002\u20131011","journal-title":"J Invest Dermatol"},{"key":"3863_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10238-017-0467-0","volume":"18","author":"Y Pan","year":"2018","unstructured":"Pan Y, Liu G, Zhou F, Su B, Li Y (2018) DNA methylation profiles in cancer diagnosis and therapeutics. Clin Exp Med 18:1\u201314","journal-title":"Clin Exp Med"},{"key":"3863_CR35","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1186\/s12967-019-2065-2","volume":"17","author":"N Xu","year":"2019","unstructured":"Xu N, Wu Y, Ke Z, Liang Y, Cai H, Su W, Tao X, Chen S, Zheng Q, Wei Y, Xue X (2019) Identification of key DNA methylation-driven genes in prostate adenocarcinoma: an integrative analysis of TCGA methylation data. J Transl Med 17:311","journal-title":"J Transl Med"},{"key":"3863_CR36","doi-asserted-by":"publisher","first-page":"5215","DOI":"10.1038\/sj.onc.1207647","volume":"23","author":"J Worm","year":"2004","unstructured":"Worm J, Christensen C, Gronbaek K, Tulchinsky E, Guldberg P (2004) Genetic and epigenetic alterations of the APC gene in malignant melanoma. Oncogene 23:5215\u20135226","journal-title":"Oncogene"},{"key":"3863_CR37","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.tiv.2014.10.020","volume":"29","author":"M Venza","year":"2015","unstructured":"Venza M, Visalli M, Biondo C, Oteri R, Agliano F, Morabito S, Teti D, Venza I (2015) Epigenetic marks responsible for cadmium-induced melanoma cell overgrowth. Toxicol Vitro 29:242\u2013250","journal-title":"Toxicol Vitro"},{"key":"3863_CR38","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/j.1755-148X.2011.00828.x","volume":"24","author":"K Conway","year":"2011","unstructured":"Conway K, Edmiston SN, Khondker ZS, Groben PA, Zhou X, Chu H, Kuan PF, Hao H, Carson C, Berwick M, Olilla DW, Thomas NE (2011) DNA-methylation profiling distinguishes malignant melanomas from benign nevi. Pigment Cell Melanoma Res 24:352\u2013360","journal-title":"Pigment Cell Melanoma Res"},{"key":"3863_CR39","doi-asserted-by":"publisher","first-page":"e18674","DOI":"10.1371\/journal.pone.0018674","volume":"6","author":"EJ Ekstr\u00f6m","year":"2011","unstructured":"Ekstr\u00f6m EJ, Sherwood V, Andersson T, Hotchin NA (2011) Methylation and loss of secreted frizzled-related protein 3 enhances melanoma cell migration and invasion. PLoS One 6:e18674","journal-title":"PLoS One"},{"key":"3863_CR40","doi-asserted-by":"publisher","first-page":"216466","DOI":"10.1016\/j.canlet.2023.216466","volume":"581","author":"X Hu","year":"2024","unstructured":"Hu X, Hu Z, Zhang H, Zhang N, Feng H, Jia X, Zhang C, Cheng Q (2024) Deciphering the tumor-suppressive role of PSMB9 in melanoma through multi-omics and single-cell transcriptome analyses. Cancer Lett 581:216466","journal-title":"Cancer Lett"},{"key":"3863_CR41","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.1007\/s00432-022-04164-1","volume":"149","author":"S Long","year":"2023","unstructured":"Long S, Zhang XF (2023) AURKA is a prognostic potential therapeutic target in skin cutaneous melanoma modulating the tumor microenvironment, apoptosis, and hypoxia. J cancer Res Clin 149:3089\u20133107","journal-title":"J cancer Res Clin"},{"key":"3863_CR42","doi-asserted-by":"publisher","first-page":"817656","DOI":"10.3389\/fgene.2022.817656","volume":"13","author":"C Huang","year":"2022","unstructured":"Huang C, Han W, Wu Y, Shen G (2022) Identification of aberrantly methylated differentially expressed genes and pro-tumorigenic role of KIF2C in melanoma. Front Genet 13:817656","journal-title":"Front Genet"},{"key":"3863_CR43","doi-asserted-by":"publisher","first-page":"868","DOI":"10.21037\/atm-19-4577","volume":"8","author":"J Liu","year":"2020","unstructured":"Liu J, Nie S, Li S, Meng H, Sun R, Yang J, Cheng W (2020) Methylation-driven genes and their prognostic value in cervical squamous cell carcinoma. Ann Transl Med 8:868","journal-title":"Ann Transl Med"},{"key":"3863_CR44","unstructured":"Hall KH, Rapini RP (2023, July 24). Acral lentiginous melanoma. In StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. Retrieved from https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK559113\/"},{"issue":"12","key":"3863_CR45","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.3390\/cancers11122031","volume":"11","author":"D Pradhan","year":"2019","unstructured":"Pradhan D, Jour G, Milton D, Vasudevaraja V, Tetzlaff MT, Nagarajan P, Curry JL, Ivan D, Long L, Ding Y, Ezhilarasan R, Sulman EP, Diab A, Hwu W, Prieto VG, Torres-Cabala CA, Aung PP (2019) Aberrant DNA methylation predicts melanoma-specific survival in patients with acral melanoma. Cancers 11(12):2031. https:\/\/doi.org\/10.3390\/cancers11122031","journal-title":"Cancers"},{"key":"3863_CR46","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.semcancer.2019.08.002","volume":"59","author":"M Marzagalli","year":"2019","unstructured":"Marzagalli M, Ebelt ND, Manuel ER (2019) Unraveling the crosstalk between melanoma and immune cells in the tumor microenvironment. Semin Cancer Biol 59:236\u2013250","journal-title":"Semin Cancer Biol"},{"key":"3863_CR47","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/ni.2703","volume":"14","author":"TF Gajewski","year":"2013","unstructured":"Gajewski TF, Schreiber H, Fu Y (2013) Innate and adaptive immune cells in the tumor microenvironment. Nat Immunol 14:1014\u20131022","journal-title":"Nat Immunol"},{"key":"3863_CR48","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1159\/000323923","volume":"3","author":"R Wehner","year":"2011","unstructured":"Wehner R, Dietze K, Bachmann M, Schmitz M (2011) The bidirectional crosstalk between human dendritic cells and natural killer cells. J Innate Immun 3:258\u2013263","journal-title":"J Innate Immun"},{"key":"3863_CR49","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1038\/s41590-020-0713-6","volume":"21","author":"BJ Laidlaw","year":"2020","unstructured":"Laidlaw BJ, Duan L, Xu Y, Vazquez SE, Cyster JG (2020) The transcription factor Hhex cooperates with the corepressor Tle3 to promote memory B cell development. Nat Immunol 21:1082\u20131093","journal-title":"Nat Immunol"},{"key":"3863_CR50","doi-asserted-by":"publisher","first-page":"108285","DOI":"10.1016\/j.celrep.2020.108285","volume":"33","author":"W Goh","year":"2020","unstructured":"Goh W, Scheer S, Jackson JT, Hediyeh-Zadeh S, Delconte RB, Schuster IS, Andoniou CE, Rautela J, Degli-Esposti MA, Davis MJ, McCormack MP, Nutt SL, Huntington ND (2020) Hhex directly represses BIM-dependent apoptosis to promote NK cell development and maintenance. Cell Rep 33:108285","journal-title":"Cell Rep"},{"key":"3863_CR51","doi-asserted-by":"publisher","first-page":"e80741","DOI":"10.1371\/journal.pone.0080741","volume":"8","author":"A Peille","year":"2013","unstructured":"Peille A, Brouste V, Kauffmann A, Lagarde P, Le Morvan V, Coindre J, Chibon F, Bresson-Bepoldin L, Castresana JS (2013) Prognostic value of PLAGL1-specific CpG site methylation in soft-tissue sarcomas. PLoS One 8:e80741","journal-title":"PLoS One"},{"key":"3863_CR52","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.arcmed.2016.07.011","volume":"47","author":"N Wang","year":"2016","unstructured":"Wang N, Sui F, Ma J, Su X, Liu J, Yao D, Shi B, Hou P, Yang Q (2016) Site-specific hypermethylation of RUNX3 predicts poor prognosis in gastric cancer. Arch Med Res 47:285\u2013292","journal-title":"Arch Med Res"},{"key":"3863_CR53","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/bjc.2012.308","volume":"107","author":"C Palmieri","year":"2012","unstructured":"Palmieri C, Monteverde M, Lattanzio L, Gojis O, Rudraraju B, Fortunato M, Syed N, Thompson A, Garrone O, Merlano M, Lo Nigro C, Crook T (2012) Site-specific CpG methylation in the CCAAT\/enhancer binding protein delta (CEBPdelta) CpG island in breast cancer is associated with metastatic relapse. Brit J Cancer 107:732\u2013738","journal-title":"Brit J Cancer"},{"key":"3863_CR54","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1111\/pcmr.12289","volume":"27","author":"NE Thomas","year":"2014","unstructured":"Thomas NE, Slater NA, Edmiston SN, Zhou X, Kuan P, Groben PA, Carson CC, Hao H, Parrish E, Moschos SJ, Berwick M, Ollila DW, Conway K (2014) DNA methylation profiles in primary cutaneous melanomas are associated with clinically significant pathologic features. Pigment Cell Melanoma Res 27:1097\u20131105","journal-title":"Pigment Cell Melanoma Res"},{"key":"3863_CR55","doi-asserted-by":"publisher","first-page":"4014","DOI":"10.1038\/sj.onc.1207505","volume":"23","author":"DSB Hoon","year":"2004","unstructured":"Hoon DSB, Spugnardi M, Kuo C, Huang SK, Morton DL, Taback B (2004) Profiling epigenetic inactivation of tumor suppressor genes in tumors and plasma from cutaneous melanoma patients. Oncogene 23:4014\u20134022","journal-title":"Oncogene"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-03863-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-025-03863-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-03863-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T13:15:48Z","timestamp":1741698948000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-025-03863-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,11]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3863"],"URL":"https:\/\/doi.org\/10.1007\/s00403-025-03863-2","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,11]]},"assertion":[{"value":"5 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"545"}}